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ABSTRACT
Translational repression and deadenylation of eu-
karyotic mRNAs result either in the sequestration of
the transcripts in a nontranslatable pool or in their
degradation. Removal of the 50 cap structure is a
crucial step that commits deadenylated mRNAs to
50-to-30 degradation. Pat1, Edc3 and the DEAD-box
protein Dhh1 are evolutionary conserved factors
known to participate in both translational repression
and decapping, but their interplay is currently
unclear. We report the 2.8 A˚ resolution structure of
yeast Dhh1 bound to the N-terminal domain of Pat1.
The structure shows how Pat1 wraps around the C-
terminal RecA domain of Dhh1, docking onto the
Phe-Asp-Phe (FDF) binding site. The FDF-binding
site of Dhh1 also recognizes Edc3, revealing why
the binding of Pat1 and Edc3 on Dhh1 are mutually
exclusive events. Using co-immunoprecipitation
assays and structure-based mutants, we demon-
strate that the mode of Dhh1-Pat1 recognition is
conserved in humans. Pat1 and Edc3 also interfere
and compete with the RNA-binding properties of
Dhh1. Mapping the RNA-binding sites on Dhh1 with
a crosslinking–mass spectrometry approach shows
a large RNA-binding surface around the C-terminal
RecA domain, including the FDF-binding pocket. The
results suggest a model for how Dhh1-containing
messenger ribonucleoprotein particles might be re-
modeled upon Pat1 and Edc3 binding.
INTRODUCTION
The fate of eukaryotic mRNAs is linked to the complement
of proteins with which they associate to form messenger
ribonucleoprotein particles (mRNPs) (1). The 50 cap
structure and the 30 poly(A) tail are general hallmarks of
mRNPs that are targeted, either directly or indirectly, by
translation factors as well as mRNA decay factors.
Translation and decay are mutually dependent and antagon-
istic processes. The presence of the m7G cap structure at the
50 end, for example, is crucial for eIF4E binding and for
translation initiation [reviewed in (2)]. Conversely, its
removal by the decapping complex is a prerequisite for
50–30 degradation by the exoribonuclease Xrn1 [reviewed in
(3)]. Shortening of the poly(A)-tail is also linked to the shift of
mRNA from active translation to a translationally repressed
state in which the transcript can either be temporarily stored
or can be decapped and degraded [reviewed in (4)].
Although the exact sequence of events and interplay of
the factors involved in translational repression,
deadenylation and decay is currently debated, it is clear
that removal of the cap structure is an irreversible step
that commits the mRNA to 50–30 degradation [reviewed
in (3)]. Studies originally in yeast have shown that
decapping is catalyzed by Dcp1-Dcp2 (5,6) and is
activated in vivo by a cohort of regulators, including
Pat1, Edc3, Scd6, Dhh1 and the heptameric Lsm 1–7
complex (7–12). These core components of the decapping
machinery are conserved from yeast to humans, suggest-
ing the presence of common basic mechanisms (13).
Additional components as well as detailed intermolecular
interactions can, however, vary across species. All compo-
nents of the decapping/50–30 decay pathway co-localize in
P-bodies together with factors involved in translational
repression [reviewed in (14–17)]. Two P-body components
in particular, Dhh1 and Pat1 (18–24), appear to be at the
intersection of translational repression and mRNA
turnover [reviewed in (25,26)].
Pat1 is a conserved multidomain protein that forms a
scaffold for protein–protein interactions: the N-terminal
domain (NTD) binds Dhh1, the downstream region is
important for P-body formation and the middle and
C-terminal domains recruit a plethora of factors, including
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the decapping complex Dcp1–Dcp2, the Ccr4–Not complex,
the Lsm1–7 complex and Xrn1 (22–24,27). The Ccr4–Not
complex is amajor deadenylase: it trims themRNA30 end to
a short oligoadenylated tail that forms the platform for the
Lsm1–7 complex [reviewed in (28)]. Mechanistically, Pat1 is
thus believed to link the deadenylated 30 end with the
decapping factors at the 50 end. Indeed, Pat1 triggers
deadenylation when tethered to mRNAs in human and
Drosophila cells (22,24) and leads to a strong effect in
decapping upon deletion in yeast (8,9). In addition to its
prevalent role in mRNA degradation, in yeast Pat1 acts as
a translational repressor together with Dhh1 (18).
Dhh1 (also known as RCK/p54/DDX6 in humans,
Me31b in Drosophila melanogaster and CGH-1 in Caenor-
habditis elegans) has been known as a decapping activator
since the finding 10 years ago that its deletion in
Saccharomyces cerevisiae stabilizes mRNA transcripts and
inhibits decapping in vivo (10,11). However, Dhh1 does not
appear to function like Pat1 and Edc3/Sdc6 by directly
binding and activating the Dcp1–Dcp2 decapping
complex (27,29). Evidence is instead accumulating
pointing to a prevalent role of Dhh1 in translational repres-
sion in yeast (18,30) as well as in higher eukaryotes (21,31–
35). Dhh1 is highly abundant in all species examined to date
[yeast (36), Trypanosoma (37), Xenopus oocytes (38) and
mammalian cells (39)] and is present in large excess over the
expected mRNA substrates (39,40–42). Dhh1 belongs to the
DEAD-box protein family of RNA-dependent ATPases,
but has several unusual features. While other DEAD-box
proteins bind RNA and ATP in a cooperative manner (43),
Dhh1 binds RNA even in the absence of ATP (39,44). In
addition, the two RecA-like domains of Dhh1 are not
flexible as in most other DEAD-box proteins, but are
engaged in intramolecular interactions (45). This conform-
ational rigidity restricts the ATPase activity of Dhh1 in vitro
(44,45). In vivo, the ATPase activity of yeast Dhh1 is none-
theless critical for the dissociation from P-bodies (44,46).
Dhh1 and Pat1 are emerging as crucial players in guiding
the mRNPs from a translationally repressed state to a
decapping state. The C-terminal RecA-like domain
(RecA2) of Dhh1 is sufficient for translational repression
and accumulation in P-bodies in human cells (21). Studies
with the Drosophila orthologues have shown that this
domain of Dhh1 binds in a mutually exclusive manner
Edc3 and Scd6 (known as TraI in flies) (47), two partially
redundant proteins with a similar domain organization
(12). The C-terminal RecA-like domain is also required
to bind Pat1 (22). In this work, we have elucidated the
evolutionary conserved molecular mechanisms of the inter-
action between Dhh1 and Pat1, showing how Pat1 and
Edc3 compete for the same surface of Dhh1 and how
they impact on RNA binding. These results suggest that
Dhh1 might switch protein and RNA-binding partners in
the transition from translational repression to decapping.
MATERIALS AND METHODS
Protein expression and purification
S. cerevisiae Dhh130–425 and Dhh146–422 were cloned as
Tobacco etc virus (TEV)-cleavable His6-GST-tag fusion
proteins. They were expressed in BL21-Gold (DE3)
pLysS (Stratagene) in Terrific Broth medium. Cells were
resuspended in lysis buffer (20mM Tris, pH 7.4, 200mM
NaCl) supplemented with 10mM imidazole, DNase,
lysozyme and phenylmethylsulfonyl fluoride, and lysed
by sonication. Proteins (wild type and mutants) were
purified using Nickel-based affinity chromatography.
Point mutations were introduced by QuickChange site–
directed mutagenesis according to the manufacturer’s in-
struction (Stratagene). The His6-GST tag was either kept
or cleaved by overnight incubation with TEV. Proteins
were further purified by ion exchange chromatography
at pH 7.4 (Heparin, GE healthcare) followed by size-ex-
clusion chromatography (Superdex 75, GE Healthcare).
S. cerevisiae Pat11–30, Pat11–56, Pat11–114 and Pat15–79
proteins were expressed as TEV-cleavable GST-His-
tagged proteins in BL21-Gold (DE3) pLysS cells. The
cells were resuspended in lysis buffer and disrupted by
sonication. The proteins were purified by Nickel-based
affinity chromatography and then subjected (either
tagged or untagged following the addition of
TEV protease) to ion exchange chromatography at pH
8.0 (MonoQ 5/50, GE healthcare) and to size exclusion
chromatography (Superdex 75). For isothermal titration
calorimetry (ITC), Pat1 proteins were subcloned with a
His6-SUMO tag. S. cerevisiae Edc377–158 was subcloned
with His6-GST tag, while Edc377–158 and Edc377–116 were
subcloned as cleavable His6-SUMO proteins. All proteins
were expressed and purified following similar protocols
as the ones described above. For crystallization, the
His6-SUMO tag was cleaved using the SUMO protease
Senp2.
The complexes of yeast Dhh1 with Pat1 or Edc3 were
reconstituted by incubating the individually purified
proteins in a 1:1.5 molar ratio for 1 h at 4C. Dhh1–
Pat1 and Dhh1–Edc3 were further purified by size exclu-
sion chromatography (Superdex 75) in a buffer containing
20mM Tris, pH 7.4, 150mM NaCl, 1mM DTT.
Crystallization and structure determination
Crystallization was carried out at 18C using the vapor
diffusion method by mixing equal volumes of protein
complex at 27mg/ml and of crystallization buffer. The
best diffracting crystals of Dhh146–422 K234D, V238D
Pat15–79 complex were obtained in 50mM Tris, pH 8.0,
4% MPD, 200mM NaCl, 25% PEG 400 after 10 days.
Crystals were flash-frozen in liquid nitrogen directly from
the crystallization drop. Crystals of Dhh146–422 K234D,
V238D Edc377–158 were obtained with 50mM MES, pH
6.5, 5% PEG 400, 0.1M KCl, 10mMMgCl2. The crystals
were cryoprotected by adding glycerol and diffracted to
3.5 A˚ resolution (data not shown). Crystals of Dhh146–422
K234D, V238D and Edc377–116 were obtained at 19mg/ml
concentration of the complex and 50mM MES, pH 6.0,
10% MPD within 5 days. Crystals were flash-frozen by
adding 25% glycerol in the crystallization buffer and dif-
fracted to 3.25 A˚ resolution.
All diffraction data were collected at 100K at the
beamline PXII of the Swiss Light Source synchrotron
and processed using XDS. The structures were determined
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by molecular replacement with the program Phaser (48)
using the two RecA domains from the apo Dhh1 structure
(45) as search models. The atomic model was built with
the program Coot (49) and refined with PHENIX (50).
The data collection and refinement statistics are
summarized in Table 1.
In vitro pull-down assays
Experiments were performed by mixing 3 mg of GST-
tagged (bait) protein with equal molar amounts of
untagged (prey) protein. Binding buffer (20mM Hepes,
pH 7.5, 250mM NaCl, 2mM MgAc2, 10% glycerol,
2mM imidazole, 1mM DTT, 0.1 % Nonidet 40) was
added to a final volume of 60 ml. The reaction mixtures
were incubated on ice for 1–2 h. Fifteen microliters of 50%
(v/v) suspension of GSH–Sepharose beads in 200 ml of
binding buffer was added to each reaction mixture and
incubated at 4C for 1 h. Beads were washed three times
with 500 ml binding buffer. Bound proteins were eluted
with 20mM reduced glutathione. Samples were separated
on sodium dodecyl sulphate-polyacrylamide gel electro-
phoresis (SDS-PAGE) and visualized by Coomassie blue
stain.
In vitro RNA-binding assays
The experiments were carried out essentially as previously
described (52). Single-stranded 50 biotinylated U20 RNA
(Dharmacon) was mixed with 3 mg of a given protein and/
or nucleotide in binding buffer (20mM Hepes, pH 7.5,
50mM NaCl, 10mM MgCl2, 1mM DTT, 10% glycerol,
0.1% Nonidet 40) to a final volume of 60 ml and was kept
at 4C overnight. Each reaction was then supplemented
with 200 ml of binding buffer and 50 mg of preblocked
magnetic streptavidin beads (Dynal) for 2 h, rocking at
4C. Beads were washed three times with 500ml of
binding buffer. Proteins were eluted from the beads with
17 ml SDS loading buffer. Eluted samples were boiled for
5 min and analyzed on SDS-PAGE.
Isothermal titration calorimetry
Dhh130–425 and His6-SUMO tagged Pat15–56, Pat15–79 or
Pat15–114 proteins were dialyzed overnight in the same
buffer (20mM Hepes, pH 7.5, 150mM NaCl, 1mM
TCEP). ITC experiments were carried out at 25C with
a VP-ITC Microcal calorimeter (Microcal, GE health-
care). The MicroCal cell was filled with Dhh130–425 at
17 mM concentration. For each titration, Pat1 was
injected into the cell 45 times in 10 ml volumes per injection
at the same intervals of time (5min). The concentration of
Pat1 in the syringe was 10 times the concentration of
the protein sample in the cell. The released heat was
obtained by integrating the calorimetric output curves
and was corrected for the effect of dilution by carrying
out a control experiment, titrating Pat1 against the
buffer in the cell. The Kd values and binding ratios were
calculated with the Origin (V7) software supplied with the
calorimeter. We used a similar protocol to measure the Kd
of Dhh130–425 and Edc377–158.
Co-immunoprecipitation assays
HEK293T cells were cultured in Dulbecco’s modified
Eagle medium containing 10% fetal bovine serum
(Gibco), 100U/ml penicillin and 0.1mg/ml streptomycin
(Gibco) at 37C/5% CO2. Plasmids were transfected with
Table 1. Data collection and refinement statistics. The Ramachandran plot was calculated using the program
Molprobity (59)




Space group P4122 P4122
Cell dimensions
a, b, c (A˚) 105.6, 105.6, 122.1 105.8, 105.8, 124.6
Data collection
Wavelength (A˚) 0.9714 0.9796
Resolution (A˚) 48.47–2.80 (2.90–2.80) 80.68–3.25 (3.36–3.25)
Rmerge (%) 7.6 (75.8) 9.2 (120.4)
I / (I) 18.3 (2.8) 23.5 (2.4)
Completeness (%) 99.6 (96.17) 99.7 (97.47)
Multiplicity 6.8 17.3
Refinement
Resolution (A˚) 53.11–2.80 53.70–3.25
No. of unique reflections 17 636 11 712
Rwork / Rfree (%) 20.42/24.71 20.85/24.57





R.m.s.d. bond lengths (A˚) 0.003 0.003
R.m.s.d. bond angles () 0.743 0.790
Ramachandran outliers (%) 0.00 0.25
Ramachandran favored (%) 97.51 98.25
Values in parentheses are for the highest-resolution shell.
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polyethyleneimine (Polysciences Inc., 1mg/ml) for protein
interaction studies. HEK293T cells were collected from
confluent 6-cm dish after 24 h of transient transfection.
Cells were lysed in 300ml of lysis buffer containing
10mM Tris, pH 7.5, 10mM NaCl, 10mM EDTA, 0.5%
Triton X-100 and protease inhibitors (Roche). Lysate was
centrifuged at 1000g for 5min at 4C. Thirty microliters of
GFP binder protein sepharose beads were added to super-
natant for 1 h at 4C. Beads were washed five times with
1ml of NET2 buffer (50mM Tris, pH 7.5, 150mM NaCl,
0.05% Triton X-100) and proteins were eluted with 40 ml
SDS sample buffer containing 5% b-mercaptoethanol.
Eluted proteins were run on 12% polyacrylamide gels
and transferred onto nitrocellulose membrane (0.45 mm
pore size) (Whatman Protran BA85) for western
blotting. Mouse monoclonal anti-GFP (Santa Cruz bio-
technology, sc-9996) and anti-HA (Covance, MMS-101R)
antibodies and horseradish peroxidase–coupled goat anti-
mouse (Millipore, AQ502A) secondary antibody were
used in combination with ECL prime western blotting de-
tection reagent (GE healthcare) for detection of HA- and
GFP-tagged proteins via western blotting.
Crosslinking–mass spectrometry analysis
The protein–RNA contacts site on Dhh1 were investigated
with mass spectrometry after UV-induced protein–RNA
crosslinking as described in (53). The purified crosslinks
were analyzed using Top10HCD method on an Orbitrap
Velos instrument and the data were analyzed using
OpenMS and OMSSA as a search engine (see Supplemen-
tary Methods).
RESULTS AND DISCUSSION
Biochemical and biophysical characterization of the yeast
Dhh1–Pat1 interaction
S. cerevisiae Pat1 is an 88 kDa protein containing an NTD
followed by a proline-rich region, a middle domain and a
C-terminal domain (20,22) (Figure 1A). Dhh1 contains
two RecA-like domains (RecA1 and RecA2) flanked by
N-terminal and C-terminal low-complexity regions (45)
(Figure 1A). The NTD of Pat1 is conserved from yeast
to humans and has been shown in the case of the D.
melanogaster and human proteins to mediate the inter-
action with the corresponding Dhh1 orthologues using
co-immunoprecipitation assays (22,23). This domain is
also part of a larger region found to strongly bind Dhh1
in the case of the yeast proteins (27).
To investigate the S. cerevisiae Dhh1–Pat1 complex, we
first narrowed down the interacting domains using pull-
down assays with recombinant Dhh1 and GST-tagged
Pat1 proteins. The NTD of yeast Pat1 (residues 1–114) ef-
ficiently precipitated the DEAD-box core of Dhh1 (residues
30–425, including RecA1 and RecA2) (Figure 1B, lane 9).
A segment of the Pat1 NTD that we engineered based on
evolutionary conservation (residues 1–56) was also able to
precipitate Dhh130–425 (Figure 1B, lane 8), while no binding
was observed when using a fragment of Pat1 encompassing
residues 1–30 (Figure 1B, lane 7). To experimentally
identify a Pat1 segment suitable for structural studies, we
purified the complex of Dhh130–425 and Pat11–114 and sub-
jected it to limited proteolysis. Treatment with the protease
chymotrypsin resulted in the accumulation of a fragment
that we characterized using mass spectrometry analysis and
N-terminal sequencing as corresponding to Pat1 residues
5–79 (Figure 1C).
Next, we assessed binding affinities quantitatively using
ITC. In the presence of 150mM salt, yeast Dhh130–425 and
Pat15–79 interacted with a Kd of 50 nM (Figure 1D, left
panel). A similar dissociation constant was obtained when
using Pat15–114 or Pat15–56 (Supplementary Figure S1),
indicating that most of the binding determinants
reside in the evolutionary conserved segment of the Pat1
NTD. Pat15–79 and the RecA2 domain of Dhh1 interacted
with a Kd of 32 nM (Figure 1D, central panel), while no
binding was detected with the RecA1 domain (Figure 1D,
right panel). We concluded that the Dhh1–Pat1 inter-
action is confined to the RecA2 domain of the DEAD-
box protein.
Crystal structure determination of a yeast Dhh1–Pat1
complex
Attempts to crystallize yeast Pat15–79 or Pat15–56 with the
RecA2 domain of Dhh1 failed, as the complexes appeared
to be too soluble to achieve the supersaturated conditions
required for nucleation. Complexes of Pat1 with
Dhh130–425 yielded the same crystal form that was previ-
ously reported for apo-Dhh1 (45), and indeed contained
only Dhh1. Inspection of this crystal form revealed that
the RecA2 domain of a Dhh1 molecule contacts the
RecA1 domain of a neighboring Dhh1 molecule in the
lattice (Supplementary Figure S2A). The surface of
RecA2 mediating crystal contacts is conserved and has
been shown in the case of the human orthologue DDX6
to bind the Phe-Asp-Phe (FDF) motif of Edc3 (35).
We reasoned that lattice contacts might promote the
dissociation of Pat1 from RecA2 during crystallization.
We therefore mutated the corresponding interacting
surface of the RecA1 domain (Supplementary Figure
S2), which did not contribute to Pat1 binding as
assessed by quantitative binding affinity measurements
(Figure 1D). For crystallization purposes, we introduced
the Lys234Asp, Val238Asp substitutions in Dhh146–422, a
construct that includes only the ordered polypeptide
region observed in the structure of apo Dhh130–425 (45).
Dhh146–422 K234D, V238D and Pat15–79 crystallized as a
complex and yielded crystals that diffracted to 2.8 A˚ reso-
lution. The structure was determined by molecular re-
placement and refined to an Rfree of 24.7%, Rwork of
20.6% and good stereochemistry (Table 1). The final
model consists of residues 46–421 of Dhh1 and residues
25–54 of Pat1 (hereafter referred to as Pat1N). No ordered
electron density was present for residues 5–24 and 55–79
of Pat1, consistent with the results from the binding assays
(Figure 1B, D and Supplementary Figure S1).
Overall structure of the yeast Dhh1–Pat1 core complex
In the complex we crystallized, Dhh1 adopts an open con-
formation (Figure 2). The relative orientation of the two
RecA domains is different from that observed in the
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Figure 1. Identification of the interacting regions of yeast Dhh1 and Pat1. (A) Schematic representation of the domain architecture of yeast Pat1
(in orange) and Dhh1 (in blue). The domain boundaries are derived from previous studies (45, 27, 22, 23) and from computational analysis. The
NTD of Pat1 refers to the segment upstream of the proline-rich (P-rich) segment. (B) Qualitative analysis of Dhh1-Pat1 interaction by GST pull-
down assays. Dhh130–425 was incubated with purified GST-tagged fragments of the Pat1 NTD (Pat11–114, Pat11–56, Pat11–30). One-sixth of the
reaction mixture was used as input and the bound fractions (precipitate) were analyzed on 4–20% SDS-NuPAGE Bis-Tris gels (Invitrogen). The
longest fragment of Pat1 NTD (Pat11–114) as well as Pat11–56 were precipitated Dhh130–425, while the shorter fragment Pat11–30 was unable to do so.
(C) Limited proteolysis experiment. The complex of Dhh130–425 and Pat11–114 was incubated at 0.6mg/ml with chymotrypsin (Roche) in a 1:10
(wt/wt) enzyme:protein ratio for 30min at 4C. The products of the proteolysis were resolved on 17% SDS-PAGE gel. (D) Quantitative analysis of
Dhh1–Pat1 interaction by ITC. The MicroCal cell was filled with Dhh1 proteins at 17 mM and His6-SUMO-tagged Pat15–79 was injected at 150mM
concentration consecutively in 10 ml volumes. The three panels correspond to the ITC experiments with Dhh130–425 (RecA1-RecA2, left), with
Dhh1251–425 (RecA2, central) and with Dhh130–250 (RecA1, right). Shown in the insets are the number of calculated binding sites (N), and the
dissociation constant (Kd), as calculated with the program Origin.
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structure of wild-type apo Dhh1 (45) (Supplementary
Figure S2B). The difference probably arises from the mu-
tations we had introduced: an intramolecular interaction
between the two RecA domains observed in the structure
of the wild-type protein (a salt bridge between Lys234 and
Glu251) is impaired by the K234D mutation (Supplemen-
tary Figure S2B). In either conformation, the residues
mutated on RecA1 are at >40 A˚ distance from the
residues that bind Pat1N (Figure 2 and Supplementary
Figure S2B). Pat1N wraps around the RecA2 domain of
Dhh1, burying 10% (9118 A˚2) of the solvent accessible
surface. Pat1N folds into an a-helical segment (residues
25–42) and an extended segment (residues 43–54)
(Figure 2).
An extended segment of yeast Pat1 docks onto the
FDF-binding site of Dhh1
The extended segment of yeast Pat1N contains a FDF
sequence motif (residues 51–53). The FDF motif binds
at a shallow surface pocket on the RecA2 domain of
yeast Dhh1 (that we refer to as the patch 1 surface)
formed by Ala263, Val265, Cys273, Leu277 and Ile409
(Figure 3A, central panel). The motif is recognized at
the same pocket and with the same conformation as
the DDX6-bound FDF motif of human Edc3 (patch 1,
Figure 3A, left panel) (35). Mutation of four residues sur-
rounding the FDF-binding site in D. melanogaster Me31b
has been previously shown by co-immunoprecipitation
studies to abolish Edc3 binding (35). We mutated the
equivalent residues at the patch 1 surface of yeast Dhh1
(Mut-1: Asn269Ala, His272Ala, Thr276Ala, Lys280Ala).
In pull-down assays with purified GST-tagged Pat15–79
and Dhh146–422 proteins, the binding of Pat1 to Mut-1
was decreased as compared with wild-type Dhh1
(Figure 3B, compare lanes 3 and 7).
In the case of human Edc3, the FDF motif is followed
by two helices that contain a conserved Phe-Asp-Lys
FDK motif and bind at a second surface patch (35)
(patch 2, Figure 3A, left panel). In the structure of yeast
Pat1N, there is no ordered extension C-terminal to the
FDF motif (Figure 3A, central panel), although this part
of the molecule is in principle present in the construct we
crystallized. We engineered a yeast Dhh1 mutant with sub-
stitutions at patch 2 (Mut-2: Phe393Ala, Tyr396Ala,
Glu399Ala, Gln400Ala) corresponding to the Me31b
mutant shown to abolish Edc3 binding in the case of the
D. melanogaster proteins (35). Consistently with the struc-
ture, yeast Pat15–79 was able to precipitate Mut-2 Dhh1
(Figure 3B, lane 6). As a control, we tested the Dhh1
mutants with yeast Edc377–158. This 80-residue long
segment of yeast Edc3 includes the equivalent 30-
residue long segment of human Edc3 that is ordered in
the structure with DDX6 (35) (Figure 4A). The Mut-1
and Mut-2 Dhh1 proteins failed to interact with
yeast Edc377–158 (Figure 3C, compare lane 3 with lanes
7 and 6). These results indicated that yeast Pat1 and
Edc3 compete for the same FDF-binding site on Dhh1
(patch 1). Yeast Pat1N, however, lacks the additional
Dhh1-binding segment at the C-terminus of the FDF
motif (patch 2) that is present in human and Drosophila
Edc3 (while absent in TraI) (35).
Figure 2. Structure of the yeast Dhh1–Pat1 core complex. The two RecA domains of Dhh1 are in blue. The Dhh1-binding domain of Pat1 spans
residues 24–54 (in orange). The structure is shown in two views related by a 90 rotation around a vertical axis. The N- and C-terminal residues
ordered in the structure are indicated. The two residues of RecA1 mutated for crystallization (K234D and V238D, shown in red) are far from the
RecA2 domain, where Pat1 binds.
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Figure 3. Hotspots of interactions on Dhh1. (A) The structure of Dhh1–Pat1 (central and right panel) is shown in comparison with the previously
determined structure of the RecA2 domain of human orthologue DDX6 (in gray) bound to another regulator, Edc3 (in salmon) (35) (left panel). The
structures in the central and left panels are in the same orientation relative to the RecA2 domain. The orientation of the Dhh1–Pat1 structure in the
right panel is related by rotations around a vertical and horizontal axis, as indicated. The close-up views show three hotspots of interactions on Dhh1
discussed in the text (patch 1, patch 2 and patch 3). Conserved residues involved in the interactions are shown in a ball-and-stick representation
(at patch 1 and patch 3 for Dhh1–Pat1, and at patch 1 and patch 2 for DDX6–Edc3). Patch 1 binds FDF motifs of yeast Pat1 and human Edc3.
Patch 2 binds the FDK motif of human Edc3 (35). Patch 3 binds an acidic segment of yeast Pat1. (B) Protein co-precipitations by GST pull-down
assays. The experiments were performed as described in Figure 1B after incubating yeast GST-tagged Pat15–79 with Dhh130–425 wild type or mutants.
Mut-1 corresponds to the N269A, H272A, T276A, K280A substitutions at Dhh1 patch1. Mut-2 corresponds to the F393A, Y396A, E399A, Q400A
at patch 2. Mut-3A corresponds to S292D, N294D and Mut3-B to R295D at patch 3. The Mut-1, Mut-3A and Mut-3B mutants of yeast Dhh1
decreased the interaction with Pat1 while Mut-2 did not, consistently with the structural analysis (Figure 3A, central and right panels). (C) Similar
pull-down experiments were performed with yeast GST-tagged Edc377–158 and Dhh130–425 wild type or mutants. The Mut-1, Mut-2, Mut-3A and
Mut-3B mutants of yeast Dhh1 all decreased the interaction with Edc3.
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The interaction at the FDF-binding site is conserved in the
human Pat1–DDX6 complex
Human and Drosophila Pat1 proteins do not contain a
FDF sequence motif. Structure-based sequence align-
ments, however, suggested the presence of an Asp-Trp
(DW) motif in metazoan Pat1 proteins at the correspond-
ing position of the yeast Pat1 FDF motif (Figure 4A). We
therefore tested whether the hydrophobic residue in the
DW motif of human Pat1b might dock on the FDF-
binding pocket of DDX6. We transiently co-expressed
full-length HA-tagged DDX6 and YFP-tagged Pat1b
residues 1–84 (hereby referred to as YFP-Pat1b) in
HEK293T cells and carried out co-immunoprecipitation
assays with GFP-binder beads. We found that a Trp46Ala
or a Trp46Asp substitution in YFP-Pat1b strongly
decreased the interaction with full-length HA-tagged
DDX6 (Figure 4B). The effect was similar to a Pat1-4A
mutant that has been recently shown to impair Dhh1
binding (54). In this assay, mutation of the FDF-binding
site in human HA-tagged DDX6 (Mut-1) significantly
decreased the interaction with YFP-Pat1b (Figure 4C).
We concluded that the interaction of Pat1 at the FDF-
binding site of Dhh1 is evolutionary conserved in yeast
and humans. Drosophila HPat is also expected to dock
at the FDF-binding site of Me31b (Figure 4A), but it is
possible that in this case the FDF-binding site contributes
less to the overall interaction, explaining previous co-
immunoprecipitation data (35).
An acidic helical segment of Pat1 docks onto a positively
charged surface of Dhh1
N-terminal to the FDF motif, Pat1N features a helical
segment that binds with extensive interactions at a third
surface patch on Dhh1 (patch 3, Figure 3A, right panel).
The helical segment of Pat1 is highly negatively charged
(Figure 4A) and binds to a positively charged surface of
Dhh1. Pat1 Asn34, Asn38, Thr41 and Asp45 make
polar contacts with Dhh1 Ser292, Asn294 and Arg295
(Figure 3A, right panel). In addition, Pat1 Glu33 forms
a salt bridge with Dhh1 Lys362 and Pat1 Phe42 makes
hydrophobic contacts with Dhh1 Leu298, Phe358 and
Arg295. The human Pat1b-4A mutant shown to disrupt
the interaction with DDX6 (54) (Figure 4B) maps to the
helical segment of Pat1 (alanine substitutions at Asp34,
Asp35, Thr36, Phe37, Figure 4A). We engineered muta-
tions in Dhh1 to disrupt patch 3. Substitutions of
Figure 4. Pat1 binds Dhh1 via evolutionary conserved residues. (A) Structure-based sequence alignment of Pat1 and Edc3 orthologues from
S. cerevisiae (Sc), Homo sapiens (Hs), D. melanogaster (Dm). Conserved residues are highlighted in orange for Pat1 and in salmon for Edc3. The
secondary structures (helices indicated as cylinders) are shown above and below the Pat1 and Edc3 sequences and correspond to the structures of the
yeast complexes reported in this manuscript. Conserved residues of yeast Pat1 and Edc3 that directly interact with Dhh1 are indicated with blue
circles and stars, respectively. (B) Co-immunoprecipitation assays of H. sapiens HA-tagged DDX6 with YFP-labeled Pat1b (residues 1–84). Wild type
and mutants (W46A, W46D and 4A) were transiently transfected in HEK293T cells. Trp46 of human Pat1b is predicted to reside at the corres-
ponding FDF motif of yeast Pat1 (panel A). The human 4A mutant corresponds to the D34, D35, T36 and F37 substitutions (53). Cell lysates
(input) were immunoprecipitated with GFP binder. HA-tagged and YFP-tagged proteins were detected by western blots. The Pat1b mutants (W46A,
W46D and 4A) impaired the interaction with wild-type DDX6. (C) Immunoprecipitation (IP) of wild-type YFP-tagged Pat1b (residues 1–84) with
HA-tagged DDX6 wild type, Mut-1 and Mut-3C. Mut-3C corresponds to the combined Mut-3A and Mut-3B substitutions (S343D, Q345D, R346D
in human DDX6). The IP was done as described above. The DDX6 mutants (Mut-1 and Mut-3C) impaired the interaction with wild-type Pat1b.
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Ser292Asp, Asn294Asp (Mut-3A) or of Arg295Asp (Mut-
3B) abolished binding to Pat15–79 in GST pull-down
assays (Figure 3B, lanes 4 and 5). The interacting
residues are conserved in the human orthologues. Indeed
a combined mutation of the Mut-3A and Mut-3B substi-
tutions in human DDX6 (Ser343Asp, Gln345Asp,
Arg346Asp or Mut-3C) impaired the interaction
with human Pat1 in co-immunoprecipitation assays
(Figure 4C).
Comparison of the structure of Dhh1–Pat1 with that of
the DEAD-box protein eIF4AIII in the exon junction
complex (EJC) (55,56) reveals that the patch 3 surface is
used in both DEAD-box proteins to recruit binding
partners (Supplementary Figure S3). The EJC is an
assembly formed by four proteins (eIF4AIII, Btz, Mago
and Y14), RNA and ATP (57). In the EJC, eIF4AIII
binds RNA with the two RecA domains in the typical
closed conformation observed in all known structures of
DEAD-box proteins in the active (RNA-ATP-bound)
state (55,56). Btz wraps around eIF4AIII and contributes
to RNA binding. The N-terminal segment of Btz contacts
RNA directly (via Phe188). In addition, Btz features
several positively charged residues (Arg176, Arg184 and
Arg185) that form a favorable electrostatic environment
for an incoming nucleic acid (Supplementary Figure S3).
The helical segment of Pat1N also approaches the
RNA-binding site expected for the ATP-bound conform-
ation, but features several surface-exposed negatively
charged residues (Glu28, Glu30, Glu32, Asp35, Asp39
and Glu40) that are predicted to electrostatically
disfavor binding of Dhh1 to nucleic acids (Supplementary
Figure S3).
Yeast Edc3 contains an acidic segment similar to Pat1
Originally as a control, we tested the Dhh1 patch 3
mutants with yeast Edc377–158 (Figure 3C). In the human
DDX6-Edc3 structure (35), there is no ordered segment
N-terminal to the FDF motif of Edc3 and therefore there
is no binding to the corresponding patch 3 surface of
DDX6. In pull-down assays, however, yeast Edc377–158
failed to interact with the Mut-3A and Mut-3B Dhh1
proteins (Figure 3C, lanes 4 and 5). As we could not ra-
tionalize these biochemical results based on the available
structural information, we set out to determine the crystal
structure of yeast Dhh1-Edc3. Yeast Dhh130–425 interacted
with Edc377–158 with a Kd of 200 nM (Supplementary
Figure S1B). The Edc377–158 construct is considerably
longer than the boundaries (residues 98–127) expected
from the structure of human Edc3 (35). Initial crystals
of the complex of yeast Dhh146–422 K234D, V238D and
Edc377–158 diffracted to 3.5 A˚ resolution. The electron
density map was of sufficient quality to show binding of
yeast Edc3 to patch 3 and to narrow down the domain
boundaries (i.e. no ordered electron density beyond
residue 116 of Edc3) (data not shown). We proceeded to
crystallize yeast Dhh146–422 K234D, V238D and
Edc377–116. The structure was determined at 3.25 A˚ reso-
lution with an Rfree of 24.6% and Rfactor of 21.0%. The
final model includes residues 46–420 of Dhh1 and residues
88–116 of yeast Edc3 (Figure 5A).
Comparison of the yeast Dhh1-Edc3 structure with that
of human DDX6-Edc3 shows a similar binding of the
FDF motif at the patch 1 surface. There is no equivalent
binding of a C-terminal helix to patch 2 (Figure 5A).
However, this is likely an artifact of crystallization, due
to a crystal contact that blocks Edc3 from accessing patch
2 of Dhh1. Indeed, binding of Dhh1 to yeast Edc377–158
was abolished by the patch 2 mutations (Figure 3C,
lane 6). More importantly, yeast Edc3 features an
ordered segment (residues 88–104) N-terminal to the
FDF motif (Figure 5A). In this segment, Trp91 of yeast
Edc3 binds in the same pocket of patch 3 as Phe42 of yeast
Pat1, explaining the results of the pull-down assays with
the patch 3 mutants (Figure 3C). Also similarly to yeast
Pat1, this segment of Edc3 is rich in negatively charged
residues (Figure 5B). While the N-terminal segment of
Pat1N is evolutionary conserved, the N-terminal segment
of yeast Edc3 is apparently not present in the human and
Drosophila orthologues. Indeed, the Mut-3C substitutions
in human DDX6 did not impair the interaction
with human Edc3 in co-immunoprecipitation assays
(Figure 5C). We concluded that these differences in the
structures of the orthologous complexes reflect genuine
differences in the interactions.
Pat1 and Edc3 disrupt RNA binding of Dhh1
We tested the effect of yeast Pat1 and Edc3 on the RNA-
binding properties of Dhh1 using a biotin-RNA pull-down
assay. In agreement with previous findings, Dhh130–425 was
precipitated by biotinylated RNA immobilized on
streptavidin beads even in the absence of nucleotide
analogs (Figure 6A, lanes 4 and 5) (44). On measuring
the affinity of Dhh130–425 for a U15 RNA by fluorescence
anisotropy, we found a Kd in the low micromolar range
(Supplementary Figure S4A), lower than that previously
reported for a full-length Dhh1 fusion protein (44), and
lower than that measured for Pat1 and Edc3 using ITC
(Figure 1D and Supplementary Figure S1). In the
presence of either Pat15–79, or Edc377–158, Dhh130–425
failed to bind to RNA in the pull-down assay (Figure 6A,
lanes 6,7 and lanes 8,9, respectively), suggesting that they
interfere with RNA binding.
Intrigued by the observation that there was no significant
difference in the RNA pull-down assays in the presence or
absence of ATP, we analyzed the nucleotide-binding
properties of Dhh1. First, inspection of the crystal structure
of apo Dhh1 (45) indicated that its closed conformation
is incompatible with ATP binding (Supplementary
Figure S4B). Dhh130–425 indeed did not bind ATP in ITC
experiments (Supplementary Figure S4C) and appeared to
be essentially inactive in RNA-dependent ATPase assays
(Supplementary Figure S4D), suggesting that Dhh1 is in
an enzymatically inactive conformation.
To map how this unusual DEAD-box protein can bind
RNA in the absence of ATP, we crosslinked Dhh130–425 to
a U15 RNA by subjecting the complex to UV irradiation at
254nm. We then used LC-MS/MS mass spectrometry to
detect and sequence peptides conjugated to the mass of an
RNA nucleotide [reviewed in (53)]. Using this approach, we
identified 6 tryptic peptides mapping to the RecA2 domain
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of Dhh1 (Figure 6B and Supplementary Figure S5). No
peptide was detected in the RecA1 domain, suggesting
that this domain is not able to bind RNA when Dhh1 is
in the enzymatically inactive conformation. However, the
flexible N-terminal region that precedes RecA1 might con-
tribute to RNA binding, as we detected an additional
peptide encompassing residues 32–44 (Supplementary
Figure S5). Within RecA2, two peptides mapped to the
canonical RNA-binding surface expected for the active
state of the DEAD-box protein (red and magenta patches
in Figure 6B). Others mapped to the outer surface of
RecA2 (green and yellow patches in Figure 6B), corres-
ponding to the patch 1 and patch 3 sites. The mass spec-
trometry analysis identified a direct crosslink between a
uridine nucleotide and Cys273 (Figure 6C), a residue in a
central position at the FDF-binding site on patch 1 (Figure
3A, central panel). Consistently, the electrostatic properties
of the RecA2 surface show patches of positive charges
along the RNA-binding surface mapped by mass-spectrom-
etry (Figure 6D). These data indicate that Dhh1 binds Pat1,
Edc3 and RNA with mutually exclusive interactions at
patch 1 and patch 3.
CONCLUSIONS
Dhh1 has a prominent pocket on the C-terminal RecA2
domain that recognizes short FDF linear motifs present in
both yeast Pat1 and Edc3. In the case of the human
orthologues, this pocket recognizes either the FDF motif
of Edc3 (35) or a DW motif in Pat1b. It is possible that
Dhh1 might bind other factors at this pocket, not neces-
sarily with a FDF motif in their sequence. A hydrophobic
pocket is present at the corresponding position in human
eIF4AIII, where it is used to bind a Tyr-containing short
linear motif of Upf3b (58). An analogous pocket is also
present in yeast eIF4A and is used to bind a Trp-contain-
ing short linear motif of eIF4G (59). Other DEAD-box
proteins might have evolved this structural feature to
recruit short motifs present in their binding factors.
While such hydrophobic pocket probably contributes
binding affinity, specificity is likely provided by binding
to additional surfaces. We note that binding of Pat1 or
Edc3 leaves a considerable surface area of Dhh1 unoccu-
pied and potentially available to other binding partners.
Because of their overlapping binding sites, Pat1 and
Edc3 cannot bind simultaneously on Dhh1. In addition,
they interfere with the RNA-binding properties of Dhh1.
Mapping the RNA-binding surfaces of Dhh1 by a
crosslinking–mass spectrometry approach suggests that
RNA wraps around the RecA2 domain, docking also at
the FDF-binding site of Dhh1 (at patch 1). In this con-
formation, in the absence of ATP, Dhh1 is in an
enzymatically inactive state. The presence of both ATP
and RNA appears to be insufficient to release the
inactive conformation of Dhh1 that arises from the stabil-
ization of an unproductive conformation of the two RecA
Figure 5. The interaction of Dhh1 and Edc3. (A) The structure of the yeast Dhh1–Edc3 core complex is shown in a similar orientation as in
Figure 3A. The two RecA domains of yeast Dhh1 are in blue and Edc3 residues 88–116 are in salmon. The two residues on RecA1 mutated for
crystallization purposes are highlighted in red. (B) Close-up view of the negatively charged residues of yeast Edc3 lining the patch 3 surface of Dhh1.
(C) Co-immunoprecipitation assays of human YFP-tagged Edc3 and HA-tagged DDX6 wild type, Mut-1 or Mut-3C were carried out as described in
Figure 4C. With the human proteins, mutations at patch 3 (Mut-3C) do not abrogate binding.
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Figure 6. Pat1 and Edc3 compete with RNA for binding to Dhh1. (A) Co-precipitation of 50 biotinylated single-stranded poly-U20 RNA with yeast
Dhh1 alone or in complex with Pat15–79 or Edc377–158. The pull-down experiments were performed with streptavidin beads [essentially as described in
(51)] and analyzed on 4–20% NuPAGE Bis-Tris gels (Invitrogen) using 20% of the total as input and bound samples. Dhh1 bound to RNA in
presence or absence of nucleotides, as previously reported (44,39). In the presence of either Pat15–79 or Edc377–158, Dhh1 binding to RNA was
impaired. (B) On the left are the peptides of RecA2 identified by mass spectrometry analysis to be crosslinked to RNA (Supplementary Figure S5).
On the right, surface representation of apo Dhh1 (45) (in light blue) with the RNA-crosslinked peptides shown in the same colors as on the right.
Shown in black is the RNA modeled after superposition with eIF4AIII-AMPNP-RNA in EJC structure upon superposition of the RecA2 domains
(54,55). Notice that, in this conformation of Dhh1, an RNA bound in the typical ATP-dependent conformation would sterically clash against the
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(continued)
domains by an extensive network of intramolecular inter-
actions (44,45). Pat1 and in yeast Edc3 are expected also
to approach the canonical ATP-dependent RNA-binding
surface (at patch 3) with a negatively charged segment,
and thus to interfere with it.
The results predict that Pat1, Edc3 and RNA bind
Dhh1 as separate steps in the pathway, pointing to the
presence of transitions in the architecture of an mRNP
as it gets targeted to decay. A working model for the
sequence and coordination of these structural rearrange-
ments is outlined below. In the cytoplasm, Dhh1 is present
in large excess and binds mRNAs in a constitutive, ATP-
independent manner (39,44,45). We envision that upon
triggering translational repression and deadenylation,
Pat1 and Edc3 binding to Dhh1 would release it from
the nonproductive ATP-independent mode of RNA
binding. This displacement would allow Dhh1 to bind
RNA in a productive ATP-dependent manner, triggering
ATP hydrolysis and dissociation from the mRNP. This
step is likely to require the binding of an activator to
release Dhh1 from the enzymatically inhibited conform-
ation. Besides the Dhh1-binding domain, Pat1 and Edc3
bridge to the Lsm complex and to the decapping complex,
respectively. Discovering the precise sequel of events that
lead to the swap between Pat1-containing and Edc3-con-
taining complexes on Dhh1 as well as the identity of the
Dhh1 activator are quests for future studies.
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